ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

ClinicalTrials.gov ID: NCT05364021

Public ClinicalTrials.gov record NCT05364021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-escalation Study to Investigate the Safety, Tolerability, PK, PD, and Exploratory Efficacy of LP352 in Subjects With Developmental and Epileptic Encephalopathies

Study identification

NCT ID
NCT05364021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Longboard Pharmaceuticals
Industry
Enrollment
52 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2022
Primary completion
Nov 15, 2023
Completion
Nov 19, 2023
Last update posted
Nov 7, 2024

2022 – 2023

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
University of Arizona - Health Sciences Center Tucson Arizona 85724
Arkansas Children's Hospital Little Rock Arkansas 72202
Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey California 90242
Children's Hospital of Orange County Orange California 92868
University of California San Francisco San Francisco California 94158
Northwest Florida Clinical Research Group Gulf Breeze Florida 32561
University of Miami Miami Florida 33136
Advent Health Orlando Orlando Florida 32803
Research Institute of Orlando Orlando Florida 32806
University of South Florida Tampa Florida 33606
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
Consultants in Epilepsy and Neurology Boise Idaho 83702
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
Spectrum Health Grand Rapids Michigan 49503
Mayo Clinic Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Boston Children's Health Physicians LLP Hawthorne New York 10532
New York University Langone Hospital - Long Island Mineola New York 11501
Northwell Health New York New York 10075
Northeast Regional Epilepsy Group Staten Island New York 10305
OnSite Clinical Solutions LLC Charlotte North Carolina 98277
Wake Forest University School of Medicine Winston-Salem North Carolina 27157
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Providence Neurological Specialties-East Portland Oregon 97213
Child Neurology Consultants of Austin Austin Texas 78757
Austin Epilepsy Care Center Austin Texas 78758
University of Utah Salt Lake City Utah 84132
University of Washington Valley Medical Center Renton Washington 98055

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05364021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2024 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05364021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →